Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206,945 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations.
Jiang YZ, Ge LP, Jin X, Fan L, He M, Liu Y, Chen L, Zuo WJ, Wu J, Liu GY, Di GH, Wang ZH, Yu KD, Shao ZM. Jiang YZ, et al. Among authors: liu y, liu gy. Breast Cancer Res Treat. 2021 Jan;185(2):371-380. doi: 10.1007/s10549-020-05940-8. Epub 2020 Sep 25. Breast Cancer Res Treat. 2021. PMID: 32975708 Clinical Trial.
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer.
Chen W, Qin Y, Wang D, Zhou L, Liu Y, Chen S, Yin L, Xiao Y, Yao XH, Yang X, Ma W, Chen W, He X, Zhang L, Yang Q, Bian X, Shao ZM, Liu S. Chen W, et al. Among authors: liu y, liu s. PLoS Biol. 2018 Jul 27;16(7):e2005869. doi: 10.1371/journal.pbio.2005869. eCollection 2018 Jul. PLoS Biol. 2018. PMID: 30052635 Free PMC article.
206,945 results
You have reached the last available page of results. Please see the User Guide for more information.